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SUMMARY: An assay is described for Day-12 spleen colony-forming cells ICFU-S-12~ and hemopoietic stem cells 
with marrow-repopulating ability ~MRA~ in the mouse using a miniaturized stroma-dependent bone marrow 
culture assay in vitro. Bone marrow cells are grown in liquid culture in microtiter wells, and the resulting 
adherent stromal ayers are depleted of all hemopoietic activity by 20 Gy gamma irradiation. Subsequently, 
single cell suspensions containing stem cells are overlaid in a fange of concentrations, and the presence of one or 
more emerging phase nonrefractive cell clones icobblestone areas~ in a single weil scored as positive. The 
frequencies of cobblestone area-forming cells I CAFC~ are then calculated by empioying Poisson statistics. It is 
shown that the CAFC Day-10 and CAFC Day-28 frequencies closely eorrelate with those of CFU-S-12 and 
MRA cells, respectively. 
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INTRODUCTION 
The hematopoietic stem cell (HSC) compartment is 
hetereogeneous, and represents a hierarchy of primitive 
cells on the basis of decreasing ability to generate new 
stem cells, decreasing pluripotentiality and proliferative 
potential, and inereasing turnover rate (10,16). 
Marrow-repopulating ability (MRA) cells, which are 
more primitive than CFU-S Day 12, are able to 
repopulate the depleted bone marrow of potentially 
lethally irradiated mice with new CFU-C, CFU-S Day 
12, and cells that rescue secondary mice from radiation- 
inflicted death (7,10-12). The assessment of CFU -S self- 
renewal (9), MRA, or long-term repopulating ability 
(LTRA) (8) neeessitates the use of in vivo (re)trans- 
plantation studies. Moreover, frequeney analysis of 
such HSC subsets requires the use of large numbers of 
miee to meet statistical requirements 6). 
The development of routine techniques for in vitro 
assessment of CFU-S and MRA-LTRA frequencies 
should significantly reduce the use of animals in the 
laboratory, and provide a possible applicatlon in human 
hematological research, where no assays exist that allow 
frequency analysis of the most primitive HSC subsets. 
The present study describes the essential methodology 
of a limiting dilution type miniaturized, long-term bone 
marrow culture ~13~, and summarizes an extensive 
correlative study of its application as an ssay of CFU- 
S-]2 and MRA numbers in a eell suspension. The 
method is based on the Iong-term bone marrow culture 
t LTBMC) in 25-cm ~ flasks (1) and is done by overlaying 
eeils on preestablished, irradiated stromal layers in 
mierotiter weih instead of flasks {15). These layers are 
hemopoietieally inactive hut still support clonal growth 
of HSC and their descendants. 
II. MATERIALS 
A. Equipment 
Incubator, fully humidified, B5060 EK/CO2, Heraeus' 
Laminar-flow hood. 
Gammacel140 dual cesium-137 gamma source, AEC 2 
Mortar and pestle, sterile. 
Inverted phase ontrast mieroseope, CK-2, Olympus ~
Multipette 4780, and sterile eombitips 5 tal, 
0030048.237, EppendorP 
Cooled centrifuge, Minifuge GIA400' 
B. Chemieals 
Beta-mereaptoethanol, 805740, Merck s 
Biotin, B4501, Sigm# 
Bovine albumin, Fraction V, A96476 
Duibeceo's modified Eagle's medium IDMEMI 
powder, 10-331-23, Flow' 
Dutton powder, 076-99999 P, GIBCO s 
Fetal bovine serum (FBSL seleeted batch for optimal 
fibroblast and CFU-C eulture, A 1115 L, Hyclone ~ 
Ferroi I I I  i-chloride, 39435 
HEPES, 043-05630 H s 
Horse serum, seleeted bateh for optimal CFU-C growth, 
034-06050 M s 
Human transferrin, OTRE 04/05, Behringwerke '° 
Hydroeortisone 21-hemisueeinate, sodium salt, H-4881 «
Hydrogenehloride 37O'/o, 13386 s 
L-Alanine, A-3534 «
L-Asparagine aeid, A-45346 
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b-Cysteine, C-8152 ~ 
L-Glutamic acid, 37102, BDH"  
L-Glutamine, 1642, Baker 12 
L-Proline, P-4655 «
Penicillin G sodium salt, A 331-45, Seromed ' '
Sodium hydrogencarbonate (NaHCO,), 6329 ~ 
Sodium hydroxide, 6498 ~ 
Sodium pyruvate, 6619 ~ 
Sodium selenite (NSeO, 5H2OI, 6607 ~ 
Streptomycin sulfate, A 331-27 '3 
Vitamin B12, V-28766 
C. SuppLies 
96 Wells microtiter plates, flat-bottomed 8 
Male CAB X C57BI/F1 fee, 10-30-wk-old; bred 
and maintained at the Erasmus University Animals 
Centre under clean conventional conditions. Do not 
use H-T histocompatability type bmc as second 
inoculum in LTBMC since they have a decreased 
long term maintenance (2,14). 
Sterile triple distiiled w ater (TDW). 
III. PROCEDURE 
A. Preparation of solutions 
1. Dutton's balanced salt solution (BSS) 
a. Dissolve 11.79 g Dutton powder in 1 liter of triple 
distilled water (TDW). 
b. Sterilize using a Õ.22-t~m filter. 
c. Store at 4 ° C in the dark. 
In the following various supplements are 
deseribed (A2-5) that allow preparation of an 
alpha-modified DMEM culture medium (A7). 
Finally, the LTBMC culture medium lA8) can then 
be prepared with solutions A6-7 and sera. 
2. Dulbecco's modification of Eagle's medium 
a. Dissolve the following in 1 liter of TDW 
13.66 g DMEM powder 
3.7 g NaHCO3 
0.4 m137% HCI 
b. See A1, b and c 
3. Supplement for alpha-modification f DMEM (500 
tal) 
a. Put each of the following agents in a separate 25- 
ml bottle and add 25 ml of TDW 
1.25 g L-alanine; dissolve at 37 ° C 
4.0 g L-asparagine acid; heat untii dissolved 
3.5 g L-cysteine; adda  few drops of 2 N HCI 
to dissolve 
2.0 g L-proline; dissolve at 37 ° C. 
5.5 g sodium pyruvate; dissolve at 37 ° C. 
b. Dissolve 2.5 g L-asparagine and 3.75 L-glutamic 
acid separately in 10 ml of 2 N NaOH and heat 
untiL dissoived. 
c. Put all dissolved agents together with 5 ml of a 
0.25 mg vitamin B12 per ml TDW stock 
solution and 5 ml of a 0.30 mg Biotin per ml 
BSS stock solution. 
d. Adjust pH to 2.0 by adding 6 N HCI and then 
adjust otal volume to 500 ml using TDW. 
e. Sterilize by passing through a 0.22-/~m filter; can 
be kept for months when stored at -- 20 ° C. 
4. Extra supplement for modilication of DMEM •220 
ml) 
a. Put the following solutions together: 
100 ml of a 200 mM L-glutamine stock solution 
(2.92 g in 100 ml TDW). 
100 rnl of a penicillin-streptomycin stock solution 
(104 U penicillin and 10 mg streptomycin  1 
ml TDW). 
10 ml of a 0.1 M beta-mercaptoethanol st ck 
solution (50 pl in 7.05 ml TDW). 
10 ml of a 10-' M sodium selenite stock solution 
(2.63 mg in 100 ml TDW). 
b. Sterilize by passing through a 0.22-t~m filter; can 
be kept for months when stored at --20 ° C. 
5. Human transferrin (Fe-saturated) 
a. Dissolve 1 g of purified human transferrin in 13 
ml of TDW 
b. Add 100 ul of a FeCL  6H20 stock solution (0.7 g 
in 10 ml TDW) 
c. See A1 b and c. 
6. Hydrocortisone stock solution (10-3 M) 
a. Dissolve 24 g of hydrocortisone 21-hemisuccinate 
sodium salt in 50 ml of TDW. 
b. Sterilize by passing through a 0.22-~m filter; can 
be kept for months when stored at --20 ° C. 
7. Alpha-modification f DMEM 
a. Add 42 ml TDW and 20 mM HEPES to 200 ml of 
DMEM to obtain osmolality of 280 mOSM. 
b. Add to 200 ml of 280 mOsMDMEM: 
2 ml alpha supplement 
4.4 ml extra supplement 
1.34 ml human transferrin 
c. Check osmolality (280 to 285 mOSM)and pH (7.2 
to 7.4) and store at 4 ° C. Protect from light. 
8. LTBMC medium 
a. Add to 200 ml of alpha-modified DMEM: 
25 ml FBS 
12.5 to 25 ml horse serum (HS) 
2.5 ml hydrocortisone stock solution 
B. Preparation of bone marrow cells (BMC) for 
establishment of stromal layers 
1. Kill mice by gassing with CO2. One mouse is 
required for setting up four microtiter plates (240 
inner wells), which suffice for determination of the 
CAFC frequency of two cell suspensions. Take o,~t 
both sets of femur and tibia and place in ice-cold 
BSS. Remove muscles and tendons using paper 
towels, and rinse bones repeatedly to free them 
from tissue remainders. 
2. Place bone in a sterile mortar (up to 100 femora and 
tibiae can be easily processed at a time) in a few 
milliliter of BSS with 5% FBS. Open bony shafts 
by grinding them with a pestle. Remove cell clumps 
from bones by repeated flushing using a wide-bore 
pipette (5 ml). Collect the cell-rich medium from 
the mortar in a centrifuge tube and let it stand for 1 
min. Collect the supernatant again and disregard 
the bony spicules at the bottom o| the tube. Do not 
make single cell suspensions. Avoid violent stirring 
of the ceU suspension at all times to preserve suf- 
ficient ceU clumps required for optimal outgrowth 
of stromal elements. 
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C. Preparation of bone marrow cells for stem teil assay 
1. Follow steps 1 and 2 as described under B. A single 
BMC suspension is made by repeated flushing of 
the celis through a wide-bore pipette and sub- 
sequent sieving the eells once through a sterile 30 to 
100-gin gauze nylon sieve, framed in a pair of 
tightly fltting concentric steeI rings that can be 
placed on top of a glass jar for collecfion of the 
sieved cells. 
D. Setting up stroma 
1. Dilute the bone marrow equivalent of orte mouse 
(two bind legs) in 52 ml of LTBMC medium. This 
volume is suffieient for filling the inner 60 wells of 
eaeh of four mierotiter plates with 0.2 ml (about 
5.105 BMC) each. The outer rim of wells may be 
filled with sterile water. 
2. Put the eultures in a fuily humidified ineubator at 
33 ° C and 10% CO2. Start ebeeking outgrowth of 
adberent clones at about Day 7. If a confluent 
adherent layer develops within less than 10 d, this is 
generally a sign of excessive macrophage outgrowth 
at the expense of fibroblastic and endothelial eells 
due to the HS batch. Inasmueh as this cir- 
eumstance is associated with unstable and poorly 
supportive stromal layers, cultures should be 
terminated in this case and initiated again with a 
lower percentage of the HS bateh used. Optimal 
layer development is associated with the ap- 
pearanee of phase eontrast nonrefraetile clones of 
round hemopoietie cells •eobblestone areas, CAs) 
under the stromal eelis. 
3. As soon as all weil bottoms in a plate are covered by 
an adherent layer, plates are grouped in piles of 
four and wrapped in plastic bags for transportation 
and irradiation. Leaving the plates unirradiated 
after reaching eonfluency may lead to retraction of 
stromal ayers at the weil borders and subsequent 
-increasing loss of layer integrity. To completely 
eradicate ndogeneous hemopoietic activity from 
the layers, plates are exposed to 20 Gy of gamma 
radiation. This treatment does not ciltieally affect 
the ability of the LTBMC to support hemopoiesis 
t3,5,17,18). 
4. One day after irradiation, the medium in the wells is 
almost completely removed by suetlon through a 
sterile vacuum-operated needle, and fresh medium 
is deposited using a Multipette by flushing along 
the weil wall to avoid dislocation of the stromal 
layer. The LTBMC medium should eontain either 
10% FBS and 10% HS, or 20% HS. Although the 
plates ean be used as of this moment for overlay of 
fresh BMC, disappearing endogeneous CAs can be 
traeed up to 3 d after irradiation. Irradiated layers 
can be maintained before reinoculation for 2 mo. 
and require a half medium change any 2 to 3 wk or 
when cultures turn acidic. 
E. Setting up iimiting dilution assay 
1. Limiting dilution assay iLDA) of a partieular eell 
suspension preferably requires the use of eight 
dilution steps, not more than two- to three-fold 
apart, and at least 15 wells per dilution (4). The 
number of cells in each aliquot is chosen so that a 
large fraetion of cultures at a certain observation 
time do not contain any CAs. Normal murine BMC 
should be diluted as follows: 50 000, 25 000, 
12 500, 6250, 3125, 1042, 347, and 116 celis per 
weil (0.2 ml), 15 wells per dilution. When 10 ml of 
2.5 )< l0 s BMC' m1-1 is prepared, this suffices to 
inoculate 20 wells with the highest cell con- 
centration and prepare all other dilutions. 
2. Wells are half reted weekly. 
F. Scoring of wells 
1. As of Day 3, wells may be inspected for the presence 
of CAs that contain at least live cells, but may 
contain up to many thousands of nonrefractile cells. 
Inspection is done at 100)< total magnification, 
using an inverted phase contrast microscope, by 
screening each weil with vertical movements of the 
specimen holder in order to avoid nausea, Counting 
should not be done within 24 h after a medium 
change due to transient release of CA cells to the 
stromal surface and resulting underestimation of
CA frequencies. A weil is regarded positive if at 
least orte CA is found. 
G. Calculation of CA-forming eeli frequencies 
1. Evaluation of the LDA is performed by the 
maximum likelihood solution 141. From the fraction 
of nonresponding cultures, using the Poisson 
equation, it is then possible to caleulate the 
frequency of CA-forming eells (CAFCs). It follows 
from this formula that if 37% of wells are negative 
an average of orte CAFC per weil has formed a 
clone. The percentage of negative wells in any 
dilution seiles is determined by the number of cells 
inoculated per weil i13). In normal borte marrow of 
a variety of mouse strains we have observed CAFC 
Day-7 frequencies between 1in 200 to 1000, and for 
CAFC Day-28 between 1 in 10 000 to 50 000. The 
equilibilum between developing and disappearing 
CAs leads to a eharacteristie apparent CA half-life 
between Day 7 and 28 of about 3.6 d, but half-lifes 
may be very different for fractionated cell 
suspensions. The method is extremely reproducible 
when using a single sex and mouse strain. 
100 
37 
10 
5 
~ r of cells overlaid (× 102 ) 
Fit;. 1. Scoring o! CAs as endpoint in limiting dilution anal)sis tff 
primitive precursor teils is strictly determined by the number of bone 
marrow cells overlaid on a preirradiated stromal layer. Inthis ex- 
periment, seven dilutions with 20 wells per aliquot counted on Day . 
indlcate a CAFC Day-7 frequeney of I in 240 bone marrow cells. 
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DISCUSSION 
The method as described should be considered aa a 
technical note to out recent publication (13) on the use o| 
LTBMC in frequency analysis of HSC subsets in vitro 
using a limiting dilution strategy. Out earlier demon- 
stration of an association between the presenee of CAs 
and replatable hemopoietie progenitor cells (CFU-C) in 
single wells tested indieates that seoring of CAs is a 
measure of the presenee of early HSC in these cultures. 
However, the presence of refractile eells on top of the 
stroma does not indicate the presence of proliferating 
clones, because these eells are mostly mature and, in the 
case of macrophages, can be present for a long time after 
hemopoietic activity has ceased in a weil. Out 
demonstration (13) that the presence of CA is strictly 
determined by the number of BMC overlaid on the 
stroma indicates ingle-hit kinetics of this system. 
In an attempt to support out earlier statement (131 
that a time-depondent cobblestone area formation exists 
that refleets the turnover time and primitiveness of 
CAFC, we have made extensive comparisons between in 
vivo (CFU-S Day 7 and Day 12, MRA teils) and in vitro 
(CAFC) assays for HSC. To this purpose we have 
prepared a variety of BMC fractions by means of 
physieal sorting using density centrifugation, cen- 
trifugal elutriation, immunomagnetie bead adherence, 
sorting on the basis of forward and perpendicular 
lightscatter, wheatgerm agglutin fluorescein isothio- 
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FIG. 2. Diagram showing high correlation between the incidence of 
CFU-S Day 12 and CAFC Day 10 (At and between the incidence of 
CAFC Day-28 and the ability of cells to generate new CFU-C in the 
irradiated femur over a 12-d period IMRA[CFU-C];  BL 
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Fit;. 3. Diagram showing the correlation coefficients between the 
CAFC frequencies as determined between Day 5 and 28 and the in- 
cidence of CFU-S Day 7 ( l l l l l l ) ,  CFU-S Day 12 I l - - I l .  and 
MRA[CFU-C] tA AL 
cyanate iFITC) aifinity or retention of rhodamine-123. 
All these methods have been described in detail [10,11 L 
and essentially provide the researcher with celi 
suspensions in which the various HSC subsets occur in 
different frequencies. Figure 2 a shows a high 
correlation between CAFC Day 10 and CFU-S Day 12 
tr = 0.940), whereas Fig. 2 b demonstrates correlation 
of CAFC Day 28 and primitive HSC with MRA lr = 
0.889). Similar correlation diagrams were made for all 
CAFC day types and collected to give Fig. 3. It is shown 
that the assay described gives excellent fitting with in 
vivo HSC assays permitting frequency analysis of the 
very primitive MRA ceils. 
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